Subscribe to Newsletter
Subspecialties Retina, Basic & Translational Research, Refractive, Cataract

Retinal Cell Death Protection

A study published in Investigative Ophthalmology & Visual Science has highlighted the potential of remote preconditioning to protect retinal cells from damage following retinal detachment (RD). The research, conducted at the University of Michigan’s Kellogg Eye Center, investigated whether prior injury to one eye (i.e., caused by retinal detachment) could potentially confer protective effects on the contralateral retina.

Preconditioning, a process where exposure to a mild injury induces resistance to subsequent damage, has been explored in various organs across medical literature, including the heart and the brain. This study extends the concept to retinal health by examining whether detachment in one eye can precondition the other against future injury.

Using a mouse model, the researchers induced RD in the right eye at different time intervals before detaching the left retina. Their subsequent analysis revealed that prior RD in one eye provided temporary protection to the contralateral retina, reducing cell death markers and inflammatory responses. The effect was most pronounced when preconditioning occurred one to three days before the second RD, but this effect diminished after seven days.

NEWS

The Ophthalmologist Presents:

The Ophthalmologist Weekly Newsletter

Enjoying yourself? There's plenty more where that came from! Our weekly newsletter from The Ophthalmologist brings you the most popular stories as they unfold, chosen by our fantastic Editorial team!

Register for our weekly newsletter

Notably, researchers observed reduced caspase-3 cleavage, a key indicator of apoptosis, in the preconditioned retinas. Additionally, the expression of inflammatory cytokines – such as TNF-alpha and CXCL10 – was significantly lower in preconditioned retinas compared to non-preconditioned ones, suggesting an anti-inflammatory protective mechanism.

The authors say that the study provides compelling evidence that remote preconditioning could serve as a novel therapeutic approach to mitigate RD-induced retinal damage, and that, by leveraging the body’s innate protective mechanisms, clinicians might be able to reduce retinal damage and preserve vision in these at-risk patients.

Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

About the Author
The Ophthalmologist
Related Product Profiles
Uncover the Unique DNA of SPECTRALIS®

| Contributed by Heidelberg Engineering

Subspecialties Retina
ForeseeHome® – remote monitoring to help detect wet AMD earlier and improve outcomes

| Contributed by Notal Vision

Product Profiles

Access our product directory to see the latest products and services from our industry partners

Here
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: